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Using common diagnostic systems together with structured interviews to assess mental disorders has made it possible to
compare diagnostic groups of mental disorders across countries. The implicit assumption is that the symptomatology of a particular
disorder as defined by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) will not vary between different
countries. However, it is conceivable that there will be some variability in the symptom patterns. The present study examines if
differences in depressive symptom patterns across European countries can be found and if there are different associations between
symptoms and the latent construct depression. Data from 4025 individuals of the European Study of the Epidemiology of Mental
Disorders (ESEMeD) project were analysed. Individuals were interviewed using the Composite International Diagnostic Interview
(CIDI 3.0). Confirmatory factor analysis was used to examine the associations between depressive symptoms and the latent construct of
depression in each country. The proportions of endorsed symptoms of depression showed only slight variation across European countries
and onlyminor tomoderate differences in the associations between depressive symptoms and the latent construct depression. The results
demonstrated that in European countries using a fully structured and standardized interview based on European-American diagnostic
concepts leads to similar results with regard to depressive symptom patterns.
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With the development of reliable and widely accepted
diagnostic systems, the Diagnostic and Statistical Manual
of Mental Disorders-III (DSM-III) and the International
Classification of Diseases (ICD-10), a common language
in psychiatry was established. The newly developed
diagnostic systems helped researchers and clinicians to
overcome the previous heterogeneity of diagnostic systems
used to define psychiatric cases. Structural classification
systems, such as the fourth edition of the Diagnostic
Statistical Manual of Mental Disorders (DSM-IV), define
mental disorders by relying on the number of symptoms to
establish diagnoses (Thakker and Ward, 1998). Based on
these modern diagnostic systems, formal structured inter-
views, such as the Composite International Diagnostic
Interview (CIDI) and the Structured Clinical Interview for
DSM-IV (SCID), were developed to facilitate the assess-
ment of mental disorders in a standardized way. Using
common diagnostic systems together with structured
interviews to assess mental disorders has made it possible
to compare diagnostic groups of mental disorders across
countries. This has beenwelcomed by epidemiologists as a
major step forward in the development of the field
(Dohrenwend, 1990). However, the implicit thesis of the
universality of psychopathology has drawn criticism from
cross-cultural psychiatrists. It has been pointed out that
diagnostic categories defined in the U.S. and Western
Europe may not exist, or may exist in different forms, in
other cultures. Therefore, the cross-cultural application of
criteria such as DSM-IV may lead to misleading results
(Littlewood, 1990), a problem that has also been alluded to
as “category fallacy” (Kleinman, 1977). A similar criticism
has also been raised against the use of the CIDI, as this
instrument was developed in the U.S. and may not be
suitable to adequately capture psychopathology in non-
western cultures (Draguns and Tanaka-Matsumi, 2003).
An implicit assumption is that the symptomatology
of a particular disorder as defined by DSM-IV will not
vary between different countries. However, it is
conceivable that there will be some variability in
symptom patterns. For example, the diagnosis of
major depression according to DSM-IV requires the
existence of at least five out of a total of nine depressive
symptoms. Following this rule, there are a number of
different symptom combinations that would lead to the
same diagnosis of major depression. Thus, it is possible
that in some countries psychomotor symptoms of
depression are more frequent compared with other
countries. This may have implications for the treatment
that is required (Sobin and Sackeim, 1997), the
prognosis of the depressive disorder (Loas, 1996), andthe willingness of someone who suffers from this
disorder to seek treatment (Galbaud du et al., 1999).
Based on data from the European Study of the Epi-
demiology of Mental Disorders (ESEMeD), we will
address the following questions:
1. Are there differences in the frequency of reported
depressive symptoms across countries using a
standardized diagnostic interview based on DSM-IV?
2. Are the symptom patterns the same when applying
the diagnostic criteria of DSM-IV for major depres-
sive disorder or are there some variations between
countries?
3. Is the association between symptoms and the latent
construct depression the same across countries?
4. Are there variations in the variance of symptoms
explained by the latent construct depression across
countries?
2. Methods
The European Study of the Epidemiology of Mental
Disorders (ESEMeD) (Alonso et al., 2002, 2004) is the
first large-scale epidemiological study in Europe that
has employed a comparable sampling strategy together
with the use of a standardized instrument translated and
adapted for use in different European countries to assess
a broad range of mental disorders.
2.1. Subjects
The ESEMeD project is a cross-sectional study based
on a stratifiedmulti-stage random sample of 21,425 adult
respondents (aged 18 years and older) living in non-
institutional settings in six European countries (Belgium
N=2419, France N=2894, Germany N=3555, Italy N=
4712, Netherlands N=2372, Spain N=5473). Owing to
differences in access to specific population data, the
sampling frame and the number of sampling stages used
to obtain the final sample differed across countries. In all
countries, except for France and the Netherlands, the first
stage consisted of municipalities, which were stratified by
region, population size or both. Selection of municipa-
lities was proportional to size within strata and was either
systematic or random depending on the country. In
France, the first stage consisted of a list of telephone
numbers, stratified by region and size of the cities. In the
Netherlands, the first stage consisted of a random sample
of addresses selected from the postal registries, with each
address having the same probability of selection. In
Germany and the Netherlands, the second stage units
already consisted of a random selection of individuals.
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one or more additional stages before the selection of the
individuals for interview. Thus, three sampling stage units
were required to obtain the final sample in Belgium,
France and Italy. In Spain, four different stages were used.
The second stage consisted of the systematic selection of
census tracts from the municipalities selected in the first
stage. The third stage consisted of the systematic selection
of households within each census tract. The interviewer
had to make a list of all households in the census tract,
systematically select six households, and secure one
interview in each of them. If he or shewas successful, then
the census tract was completed. A more detailed
description of the methods and the participants in the
ESEMeD project is provided elsewhere (Alonso et al.,
2004). The overall response rate for the six countries was
61.2%, with the highest rates in Spain (78.6%) and Italy
(71.3%), followed by Germany (57.8%), the Netherlands
(56.4%), and Belgium (50.6%) and the lowest in France
(45.9%). The project is part of the World Health
Organization—World Mental Health Survey Initiative
(Kessler and Üstün, 2000). The analyses presented in
this article are based (1) on respondents who had at least
endorsed the screening questions for depressive dis-
orders plus one out of nine symptom questions, and (2) on
respondents who fulfilled the diagnostic criteria for
lifetime DSM-IV major depressive disorder. The
resultant sub-samples include 4025 and 2590 individuals,
respectively (Belgium=489/359, France=828/642, Ger-
many=525/369, Italy=663/445, Netherlands=596/471
Spain=924/664).
2.2. Measure
Interviews were conducted in person using the World
Mental Health Survey Initiative Version of the World
Health Organization Composite International Diagnos-
tic Interview (CIDI 3.0) (Kessler and Üstün, 2004). The
CIDI 3.0 is a comprehensive, fully structured diagnostic
interview for the assessment of mental disorders. It
provides, by means of computerized algorithms, lifetime
and current (12 months and 1 month prior to the
interview) diagnoses according to the International
Classification of Diseases (ICD-10) (World Health
Organization, 1993) and the Diagnostic and Statistical
Manual of Mental Disorders (DSM- IV) (American
Psychiatric Association, 1994). It was developed to be
used by trained lay interviewers. Previous versions of
the CIDI have been shown to be reliable and valid
(Robins et al., 1988; Wittchen, 1994; Wittchen et al.,
1998). Moderate to good concordance between the CIDI
3.0 and the clinician-administered non-patient edition ofthe Structured Clinical Interview for DSM-IV (SCID)
was found (Haro et al., 2006). The CIDI 3.0 was first
produced in English and underwent a rigorous process
of adaptation in order to obtain conceptually and cross-
culturally comparable versions in each of the target
countries and languages. The translation and back-
translation of the instrument were carried out by
scientists with outstanding English language skills. All
translators were knowledgeable in American English
and culture. An expert panel was consulted to discuss
problems with regard to item wording, response
categories and the adaptation to the cultural context.
The expert group was formed by psychiatrists, psychol-
ogists, and other mental-health service experts. Focus
groups with individuals from the general population and
patients were conducted to check comprehensibility of
the interview schedule. Selection of participants in the
groups was governed by the premise that the individuals
selected should be representative of the sampling
population for the study. It was attempted to reflect the
structure of the general population in the participating
European countries as closely as possible. Finally,
interviews were conducted that served as a test for the
feasibility of the instrument in an interview situation.
These interviews were carried out by staff who had
not otherwise been involved in the translation process.
The final forward translation was translated back into
English by an independent translator, whose mother
tongue is American English. The translator had no
knowledge of the questionnaire. Discrepancies between
the forward translation and the back translation were
discussed by the expert panels. All suggested changes
were then implemented in the final version of the
questionnaire. All six translations of the depressive
symptom questions are available as Supplementary
material to the electronic publication of the manuscript.
The CIDI 3.0 is computerized in order to facilitate its
administration. It includes fully structured questions on
presence and persistence of clusters of psychiatric
symptoms followed by probes for age of onset and
lifetime course. At the beginning of the questionnaire, a
screening section (a Lifetime Psychiatric Screening
Instrument) was administered to all respondents. It
contains screening questions for mood (i.e. Major
Depression and Dysthymia) and anxiety disorders. All
participants responding positively to any of the screen-
ing questions had to complete the CIDI section of the
specific disorder prompted by that question. With regard
to depressive disorders, the following three screening
questions were asked: ‘Have you ever in your life had a
period lasting several days or longer when most of the
day you felt sad, empty or depressed?’, ‘Have you ever
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the day you were very discouraged about how things
were going in your life?’ and ‘Have you ever had a
period lasting several days or longer when you lost
interest in most things you usually enjoy like work,
hobbies, and personal relationships?’. All respondents
who answered positively to at least one of these
questions entered the depression module of the ques-
tionnaire. The symptom questions in the depression
module of the questionnaire include questions about all
symptoms in nine symptom groups necessary to make a
diagnosis according to the DSM-IV criteria. Probe items
were asked to exclude depression symptoms that were
attributable to physical causes The symptom questions
ask whether there was a time in his/her life where the
respondent was in a sad or depressed mood (Mood), has
lost interest in most things he/she usually enjoys
(Interest), has gained or lost a substantial amount of
weight (Weight), has experienced sleep disturbances
(Sleep), was agitated or slowed down (Activity), was
tired and out of energy (Energy), has experienced
feelings of guilt or worthlessness (Guilt), has lost his
normal ability to concentrate (Cognitive) or has had
recurrent thoughts of death or suicidal ideations
(Suicide). All these symptom questions refer to the
same time period of at least 2 weeks.
2.3. Statistical analysis
Descriptive statistics were calculated to assess the
proportions of symptoms endorsed in the depression
section of the interview, and confirmatory factor
analysis (CFA) was used to investigate the association
between symptoms and the latent construct depression.
Since there was no variation in the prevalence of the
mood item, it was excluded from CFA. Therefore, the
CFA is based on eight depression symptoms (Interest,
Weight, Sleep, Activity, Energy, Guilt, Cognition,
Suicide). In order to check the dimensional structure
of the dichotomous symptom variables of depression, a
one-dimensional confirmatory factor model was
adopted. It is assumed that these indicators measure
one and only one latent dimension to be called
“depression”. The estimator for this type is a robust
weighted least squares estimator using tetrachoric
correlations. The estimation procedure is described in
appendix 4 of the Technical Appendices of the Mplus
software manual (Muthén, 2004). The factor model is
considered a congeneric one, as loadings as well as the
error variances are allowed to vary, but error correla-
tions are restricted to be zero (Jöreskog, 1971). Testing
the inequality of loadings for all six countries results ina Chi-square of 187.1, df=26, and a Tucker–Lewis
Index of 0.880. Since the Tucker–Lewis does not
reach the threshold of 0.900 that indicates a good
model fit, the assumption of a unique measurement of
depression for all countries clearly has to be rejected
and the model was estimated for each country sepa-
rately. R2 measures were calculated to compare the
differences of variance of symptoms explained by the
latent construct depression across countries. The
analyses were carried out using the program Mplus
(Muthén and Muthén, 2004).
3. Results
3.1. Frequencies of reported symptoms
In Table 1 the proportions of symptoms endorsed by
respondents in the different countries, without the
application of diagnostic algorithms, are presented. The
highest rates of endorsed symptoms are found for mood
symptoms (Mood). Periods of being sad or of feeling
empty or depressed are reported by almost every
individual in the sample. The proportions show almost
no variation across countries (95.3%–97.6%). Sleep
disturbances (Sleep) range from a low of 85.4% in the
Netherlands to a high of 90.7%in France; cognitive
disturbances (Cognitive) range from a low of 76.4% in
Germany to a high of 87.9% in the Netherlands.Moderate
proportions of endorsed symptoms are reported for the
loss of the ability to concentrate (Cognitive: range from
75.6% to 87.9%), loss of interest (Interest: range from
75.4% to 83.2%) and feelings of guilt and worthlessness
(Guilt: range from 66.5% to 82.0%). The lowest overall
rates of endorsed symptoms as well as the largest
differences between countries can be found for psycho-
motor symptoms (Activity) where the proportion of
endorsed symptoms ranges from a low of 39.0% in
Germany to a high of 55.7% in Spain. The second lowest
rates of endorsed symptoms are found for suicidal
ideations and thoughts (Suicide), ranging from a low of
58.4% in Italy to a high of 69.6% in France.
In Table 1, the proportions of symptoms endorsed by
those respondents who fulfilled the diagnostic criteria of
DSM-IV for major depressive disorder are also reported.
As expected, the percentages are higher for all
symptoms across all countries. However, the symptom
patterns are quite similar to those observed without
diagnostic restrictions. Again, for instance, psychomo-
tor symptoms (Activity) are endorsed least frequently
across all countries and show the largest differences
between countries. Second lowest percentages are found
for suicidal ideations and thoughts (Suicide).
Table 1
Proportions of endorsed symptoms for the total sample and for the sub-sample with DSM-IV lifetime diagnosis of major depression (MD) (%, S.D.).
Symptom Sample Belgium France Germany Italy The Netherlands Spain
(Total N=489) (Total N=828) (Total N =525) (Total N =663) (Total N =596) (Total N =924)
(MD=359) (MD=642) (MD=369) (MD=445) (MD=471) (MD=664)
Mood Total sample 97.3 (16.0) 95.3 (21.2) 96.6 (18.2) 96.8 (17.5) 96.1 (19.3) 97.6 (15.3)
Major depression 99.4 (7.5) 96.9 (17.4) 98.6 (11.6) 97.5 (15.5) 97.2 (16.4) 98.2 (13.3)
Interest Total sample 83.2 (37.4) 81.9 (38.5) 75.4 (43.1) 78.9 (40.8) 80.7 (39.5) 78.1 (41.4)
Major depression 89.7 (30.4) 89.3 (31.0) 82.4 (38.1) 88.9 (31.3) 87.5 (33.1) 88.0 (32.5)
Weight Total sample 72.4 (44.8) 69.1 (46.2) 70.3 (45.7) 68.2 (46.6) 66.1 (47.4) 71.5 (45.1)
Major depression 76.9 (42.2) 75.2 (43.2) 75.9 (43.0) 76.6 (42.3) 71.8 (45.1) 79.8 (40.2)
Sleep Total sample 88.5 (31.9) 90.7 (29.1) 88.6 (31.8) 87.2 (33.5) 85.4 (35.3) 86.7 (40.0)
Major depression 94.4 (22.9) 95.0 (21.8) 92.4 (26.6) 92.4 (30.3) 89.8 (30.3) 92.2 (26.9)
Activity Total sample 46.0 (49.9) 45.8 (49.9) 39.0 (48.8) 41.8 (49.4) 41.1 (49.2) 55.7 (49.7)
Major depression 52.1 (50.0) 50.8 (50.0) 45.8 (49.9) 50.33 (50.1) 43.7 (49.6) 66.1 (47.4)
Energy Total sample 77.9 (41.5) 75.8 (42.8) 76.8 (42.3) 74.5 (43.6) 85.6 (35.2) 76.6 (42.3)
Major depression 84.1 (36.6) 82.6 (38.0) 87.5 (33.1) 85.8 (34.9) 91.9 (27.2) 87.0 (33.6)
Guilt Total sample 71.8 (45.1) 74.9 (43.4) 66.5 (47.3) 68.3 (46.6) 82.0 (38.4) 68.7 (46.4)
Major depression 76.0 (42.7) 80.5 (39.6) 74.3 (43.8) 78.2 (41.3) 85.1 (35.6) 76.1 (42.7)
Cognitive Total sample 76.5 (42.5) 80.3 (39.8) 76.4 (42.5) 75.6 (43.0) 87.9 (32.6) 77.8 (41.6)
Major depression 85.0 (35.8) 87.2 (33.4) 85.9 (34.8) 87.6 (32.9) 93.6 (24.4) 86.9 (33.7)
Suicide Total sample 63.6 (48.2) 69.6 (46.0) 65.3 (47.6) 58.4 (49.3) 63.3 (48.3) 60.0 (49.0)
Major depression 71.0 (45.3) 76.0 (42.7) 72.4 (44.8) 63.6 (48.2) 67.9 (46.7) 68.5 (46.5)
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Table 2 presents standardized factor loadings as
results of the CFA using the symptom items to generate
the latent factor depression. The mood item was
excluded from the confirmatory factor analysis due to
the fact that it shows almost no variation and, therefore,
does not discriminate between the countries. The
cognitive symptom (loss of concentration) shows theTable 2
Factor loadings on depression (standardized loadings).
Symptom Belgium France G
Cognitive 0.707 0.803 0
Energy 0.665 0.493 0
Activity 0.434 0.521 0
Interest 0.459 0.539 0
Guilt 0.499 0.503 0
Sleep 0.623 0.383 0
Weight 0.327 0.476 0
Suicide 0.558 0.317 0
Chi-square test of model fit 21.965 20.882 17
Value
df 15 17 16
P-value 0.1087 0.2316 0
TLI a 0.948 0.981 0
RSMEAb 0.031 0.017 0
SRMRc 0.078 0.058 0
a Tucker–Lewis Index.
b Root mean square error of approximation.
c Standardized root mean square residual.highest factor loadings across countries and ranges from
a low of 0.538 in Germany to a high of 0.806 in Spain
and 0.803 in France. Next comes loss of energy, which
ranges from 0.493 in France to 0.753 in Italy. The lowest
factor loadings are found for suicidal ideations and
thoughts, with a range from a low of 0.204 in the
Netherlands to a high of 0.558 in Belgium (this also
represents the largest difference in factor loadings across
countries). Psychomotor symptoms show the secondermany Italy The Netherlands Spain
.538 0.786 0.610 0.806
.674 0.753 0.668 0.597
.590 0.673 0.544 0.748
.669 0.678 0.641 0.669
.549 0.601 0.439 0.626
.330 0.478 0.405 0.419
.368 0.487 0.490 0.530
.206 0.270 0.204 0.420
.832 22.180 15.384 46.405
18 12 17
.3338 0.2237 0.2211 0.0001
.988 0.993 0.959 0.953
.015 0.019 0.022 0.043
.060 0.047 0.076 0.074
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Belgium to a high of 0.748 in Spain. The smallest
differences in factor loadings are found for feelings of
guilt and worthlessness, ranging from a low of 0.439 in
theNetherlands to a high of 0.626 in Spain. Looking at the
simple ranking of symptom loadings across countries, it is
clear that Italy and Spain, respectively, have the highest
factor loadings in six out of eight symptom groups
(Interest, Weight, Activity, Energy, Guilt, Cognitive),
whereas Germany and Belgium have the lowest factor
loadings in five symptom groups (Interest, Weight, Sleep,
Activity, Cognitive) compared with the other countries.
Comparing the ranking of symptom factor loadings in
each country may provide some clues to the differences in
symptom patterns across countries. In four out of six
countries, the cognitive item shows highest factor
loadings, followed by the interest item and the energy
item. The factor loadings for the loss of energy item rank
highest in Italy and second in Germany followed by the
Netherlands and Belgium. Factor loadings for the loss of
interest item rank highest in Italy and second in Germany
and Spain.
3.3. Explained variance of symptoms
The proportion of the variance of symptoms
explained by the latent construct depression is reported
in Table 3.
Lowest rates of explained variance are found for the
suicide item, which ranges from 4% in Germany and the
Netherlands to 31% in Belgium, followed by the weight
item ranging from 11% in Belgium to 28% in Spain. The
highest percentage of explained variance is reported for
the cognitive symptom. Explained variance ranges from
a low of 29% in Germany to a high of 65% in Spain. The
second highest rates of explained variance are found for
energy, with a range from 24% in France to 57% in Italy.
The activity item shows the largest differences ofTable 3
Explained variance by symptom (R2).
Symptom Belgium France Germany Italy The
Netherlands
Spain
Cognitive 0.499 0.644 0.289 0.617 0.372 0.650
Energy 0.442 0.243 0.454 0.567 0.447 0.356
Interest 0.211 0.290 0.447 0.460 0.411 0.448
Activity 0.188 0.271 0.348 0.453 0.295 0.559
Guilt 0.249 0.253 0.301 0.361 0.193 0.392
Sleep 0.388 0.146 0.109 0.228 0.164 0.175
Weight 0.107 0.227 0.136 0.237 0.240 0.281
Suicide 0.312 0.100 0.043 0.073 0.042 0.176explained variance across countries with a range from
19% in Belgium to 56% in Spain.
4. Discussion
4.1. Similarities
The data presented here show that the prevalence of
depressive symptoms as assessed with the CIDI 3.0 is
quite similar in the six European countries. The same
applies to the symptomatology of major depressive
disorder as defined by DSM-IV. Also, the association
between depressive symptoms and their standardized
factor loadings on the latent variable depression shows
only small to moderate variations across countries.
Finally, the amount of variance of the symptoms
explained by the latent construct depression shows
only minor differences between countries. These
findings indicate that the pattern of depressive symp-
toms is similar rather than different across the six
European countries and that the importance of single
symptom groups for the diagnosis of depression does
not vary a lot across these countries. Thus, measuring
depressive symptoms with a standardized interview
such as the CIDI 3.0 and applying a diagnostic
algorithm that is defined by a structural classification
system (DSM-IV) to generate diagnosis leads to quite
similar results in Western European countries. This
might be due to the fact that all countries under analysis
are comparable to a large extent with regard to their
cultural background. Our findings are in line with other
studies on depression that employed the CIDI and
reported relative consistency of symptom patterns
across different countries (Simon et al., 2002; Weissman
et al., 1996). However, this does not necessarily indicate
that the presentation of depression is universal. Studies
in countries with non-Western cultural background may
yield quite different results.
4.2. Differences
Nevertheless, there are a few remarkable differences
across countries that require further discussion.
Although, the overall differences in factor loadings are
rather small, some countries tend to be more similar to
each other than others. It was found that Italy and Spain
often show higher factor loadings compared with
Belgium and Germany in almost all symptom groups.
France and the Netherlands show moderate factor
loadings in all symptom groups. Ordering the factor
loadings for each symptom across countries, it was
found that the factor loadings in Spain and Italy rank
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and worthlessness, weight gain or loss, loss of interest
and the cognitive symptoms of depression. Compared
with these high ranks in factor loadings, it was found
that Belgium and Germany rank lowest on interest and
weight gain or loss. In addition, Germany shows low
factor loadings in suicide and sleep disturbance items.
There is no general explanation for these differences in the
literature about cross-cultural psychology.Nevertheless, it
is worth noting that the Romance countries (Italy, Spain,
France) seem to bemore similar to each other as compared
with the other countries (Netherlands, Germany, Bel-
gium). Differences in the expression of mental disorders
reported usually refer to differences found when compar-
ing non-Western with Western societies or people from
different ethnic groups within one country (Parker et al.,
2001; Iwata and Buka, 2002). In Europe, several cross-
national studies on the epidemiology of mental disorders
were conducted making use of comparable assessment
strategies (Lépine et al., 1997; Dowrick et al., 1999).
However, none of them compared the symptomatic profile
of mental disorders across countries. On the other hand,
cross-cultural research has not made use of standardized
diagnostic instruments to assess mental disorders. There-
fore, there is still a lack of theoretical considerations
regarding how to explain different symptom patterns
across countries. The presented study was intended to be
exploratory in nature and not explanatory, i.e. we have
assessedwhether there are differences in themanifestation
of depressive disorders across countries without trying to
explain these. More explanatory analyses should be
carried out in order to investigate the conditions of these
differences and their possible implications for the
treatment and course of depressive disorders.
4.3. Limitations
The results reported here should be interpreted bearing
the following limitations in mind. Although, a careful and
thorough translation procedurewas carried out in all of the
participating countries, it is still possible that the meaning
of the questions may not be the same after translating the
instrument into five different languages, i.e. the semantic
equivalence is assumed, but no linguistic analyses were
carried out to test whether the meaning across countries is
really exactly the same. Second, other contextual factors,
such as stigmatisation across countries, were not assessed.
Stigma might affect the willingness to report depressive
symptoms depending on the different cultural contexts
and, therefore, affect the sensitivity of the used instrument
(Patten, 2003). Previous studies have shown that in
societies where mental disorders are highly stigmatisedindividuals tend to express their emotional distress
through somatic complaints (Kirmayer and Groleau,
2001). In some countries, low survey response rates
were obtained. This could have led to a bias in reported
depressive symptoms. In some surveys non-response was
positively related to mental morbidity (Kessler et al.,
1995) and may, therefore, have led to an underestimation
of reported symptoms of depressive disorders.
4.4. Conclusion
The similarities found in the expression of depression
in the ESEMeD project data suggest that in European
countries using a fully structured and standardized
interview based on European-American diagnostic con-
cepts leads to similar results with regard to depressive
symptom patterns and the importance of depressive
symptoms for the diagnosis. Further investigation is
needed to explain the differences in the expression of
affective disorders across countries in more detail.
Secondary data analysis combining the ESEMeD
data with cultural variables (ecological factors, human
beliefs and values) derived from other studies such as
the EuropeanValue Studies (EVS, 2004) might be helpful
to explain the differences across countries to a greater
extent.
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